This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MEDTECH SUMMIT STARTS IN

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
18 - 22 October 2021
Virtual EventDelivered in CEST time zone

Christine Lynn Lanning
Scientist in Safety Assessment at Merck

Profile

Dr. Christine Lynn Lanning is a Distinguished Scientist in Safety Assessment at Merck.  In this role, she provides oversight of the biocompatibility of medical devices and medical device combination products.  She has a PhD from Duke University in Pharmacology/Toxicology and is Six Sigma Green and Black Belt Certified. She has been at Merck over 22 years with experience with both drug and device development.  She has authored over 200 scientific reports and over 50 regulatory submissions.

Agenda Sessions

  • Case Study: Planning for Biocompatibility Testing and Interpreting the Results

    On Demand